Herramientas precisas en el diagnóstico oportuno de tumores gastrointestinales.
Barra lateral del artículo
Contenido principal del artículo
Resumen
El diagnóstico oportuno de los tumores gastrointestinales es crucial para mejorar la supervivencia de los pacientes. Tradicionalmente, la histopatología ha sido la herramienta principal, sin embargo, la identificación de biomarcadores específicos, como aquellos derivados del microbioma intestinal, el microambiente tumoral y el análisis de biopsias líquidas, están revolucionando el campo de la detección temprana. Además, el uso de microarreglos de tejidos, y la inmunohistoquímica junto con la patología computacional combinada con el aprendizaje automático, está transformando el análisis de imágenes histopatológicas al identificar patrones sutiles en las imágenes que pueden mejorar la precisión diagnóstica y descubrir nuevos biomarcadores asociados incluso con el pronóstico y terapia blanco. La convergencia de la histopatología tradicional, la biología molecular, la inmunología y la inteligencia artificial está generando un panorama prometedor para el diagnóstico temprano y preciso de los tumores gastrointestinales.
Detalles del artículo
Citas en Dimensions Service
Citas
Balasenthil, S., …y Killary, A. M. (2017). A plasma biomarker panel to identify surgically resectable early-stage pancreatic cancer. Journal of the National Cancer Institute, 109(8), djw341. https://doi.org/10.1093/jnci/djw341
Elliott, D. R. F., …y Fitzgerald, R. C. (2017). A non-endoscopic device to sample the oesophageal microbiota: a case-control study. The Lancet Gastroenterology and Hepatology, 2(1), 32-42. https://doi.org/10.1016/s2468-1253(16)30086-3
El-Serag, H. B., y Davila, J. A. (2011). Surveillance for hepatocellular carcinoma: in whom and how? Therapeutic Advances in Gastroenterology, 4(1), 5-10. https://doi.org/10.1177/1756283X10385964
Fisher, Y., y Hershkovitz, D. (2016). Molecular and morphometric tools for next-generation pathology diagnosis of colon carcinoma. The Israel Medical Association Journal, 18(7), 426-432.
GCO (Global Cancer Observatory) (2025). Cancer Today. Lyon, France: International Agency for Research on Cancer. https://gco.iarc.fr/
Gonzalez, R. S. (2020). Updates and challenges in gastrointestinal pathology. Surgical Pathology Clinics, 13(3), ix. https://doi.org/10.1016/j.path.2020.06.003
Jones, J. L., Poulsom, R., y Coates, P. J. (2023). Recent advances in pathology: the 2023 Annual Review Issue of The Journal of Pathology. The Journal of Pathology, 260(5), 495-497. https://doi.org/10.1002/path.6192
Kai, K., Masuda, M., y Aishima, S. (2017). Inverse correlation between CD8+ inflammatory cells and E-cadherin expression in gallbladder cancer: Tissue microarray and imaging analysis. World Journal of Clinical Cases, 5(1), 1-8. http://dx.doi.org/10.12998/wjcc.v5.i1.1
Kashyap, S., …y Saini, R. V. (2022). Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers. Seminars in Cancer Biology, 86(parte 3), 643-651. https://doi.org/10.1016/j.semcancer.2021.04.020
Korbar, B., …y Hassanpour, S. (2017). Deep learning for classification of colorectal polyps on whole-slide images. Journal of Pathology Informatics, 8, 30. https://doi.org/10.4103/jpi.jpi_34_17
Kuntz, S., …y Brinker, T. J. (2021). Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review. European Journal of Cancer, 155, 200-215. https://doi.org/10.1016/j.ejca.2021.07.012
Kwon, M. J., …y Lee, W. J. (2009). Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors. Pathology International, 59(12), 851-856. https://doi.org/10.1111/j.1440-1827.2009.02465.x
Leon-Cabrera, S., Schwertfeger, K. L., y Terrazas, L. I. (2019). Inflammation as a target in cancer therapy. Mediators of Inflammation, 2019, 1971698. https://doi.org/10.1155%2F2019%2F1971698
Lieberman, D. A., …y Levin, T. R. (2012). Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology, 143(3), 844-857. https://doi.org/10.1053/j.gastro.2012.06.001
Marrelli, D., …y Roviello, F. (2001). Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. The American Journal of Surgery, 181(1), 16-19. https://doi.org/10.1016/s0002-9610(00)00549-3
Martín-Lorenzo, J. G., …y Carrasco-González, L. (2006). Tumores gástricos estromales. Diagnóstico, pronóstico y tratamiento quirúrgico actual. Seguimiento de 18 pacientes tratados Cirugia Española, 79(1), 22-27. https://doi.org/10.1016/s0009-739x(06)70809-0
Mungenast, F., …y Ecker, R. C. (2021). Next-generation digital histopathology of the tumor microenvironment. genes, 12(4), 538. https://doi.org/10.3390/genes12040538
Murphy, N., Jenab, M., y Gunter, M. J. (2018). Adiposity and gastrointestinal cancers: Epidemiology, mechanisms and future directions. Nature Reviews Gastroenterology and Hepatology, 15(11), 659-670. https://doi.org/10.1038/s41575-018-0038-1
Rubin, G., …y de Wit, N. (2018). Reimagining the diagnostic pathway for gastrointestinal cancer. Nature Reviews Gastroenterology and Hepatology, 15(3), 181-188. https://doi.org/10.1038/nrgastro.2018.1
Sánchez-Ramírez, D., …y Montesinos, J. J. (2022). High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma. European Journal of Histochemistry, 66(1), 3360. https://doi.org/10.4081/ejh.2022.3360
Sánchez-Ramírez, D., …y Terrazas, L. I. (2024). Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression. World Journal of Gastrointestinal Oncology, 16(5), 1705-1724. https://doi.org/10.4251/wjgo.v16.i5.1705
Saremi, N. y Lam, A.K. (2018). Application of tissue microarray in esophageal adenocarcinoma. En A. Lam (Ed.). Esophageal adenocarcinoma. Methods in molecular biology (pp. 105-118). Humana Press. https://doi.org/10.1007/978-1-4939-7734-5_10
Schiffman, J. D., Fisher, P. G., y Gibbs, P. (2015). Early detection of cancer: Past, present, and future. American Society of clinical oncology educational book. https://doi.org/10.14694/EdBook_AM.2015.35.57
Shaw, V. E., …y Costello, E. (2014). Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease. Molecular Cancer, 13, 114.
https://doi.org/10.1186/1476-4598-13-114
Siegel, R. L., Giaquinto, A. N., y Jemal, A. (2024). Cancer statistics, 2024. CA Cancer Journal for Clinicians, 74(1), 12-49. https://doi.org/10.3322/caac.21820
Simon, R., Mirlacher, M., y Sauter, G. (2005). Tissue microarrays. Methods in Molecular Medicine, 114, 257-268. https://doi.org/10.1385/1-59259-923-0:257
Stahl, P. R., …y Quaas, A. (2015). Determination of tumor heterogeneity in colorectal cancers using heterogeneity tissue microarrays. Pathology & Oncology Research, 21(4), 1183-1189. https://doi.org/10.1007/s12253-015-9953-4
Sturgeon, C. M., Lai, L. C., y Duffy, M. J. (2009). Serum tumour markers: how to order and interpret them. TheBMJ, 339, b3527. https://doi.org/10.1136/bmj.b3527
Tao, Y., …y Lu, Z. J. (2023). Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood. Cell Reports Medicine, 4(11), 101281. https://doi.org/10.1016/j.xcrm.2023.101281
Ursell, L. K., …y Knight, R. (2014). The intestinal metabolome-an intersection between microbiota and host. Gastroenterology, 146(6), 1470-1476. https://doi.org/10.1053/j.gastro.2014.03.001
Verghese, G., …y Grigoriadis, A. (2023). Computational pathology in cancer diagnosis, prognosis and prediction-present day and prospects. The Journal of Pathology, 260(5), 551-563. https://doi.org/10.1002/path.6163
Wei, J. W., …y Hassanpour, S. (2020). Evaluation of a deep neural network for automated classification of colorectal polyps on histopathologic slides. JAMA Network Open, 3(4), e203398. https://doi.org/10.1001/jamanetworkopen.2020.3398
Zhang, H., y Sun, L. (2018). When human cells meet bacteria: precision medicine for cancers using the microbiota. American Journal of Cancer Research, 8(7), 1157-1175.
Zhang, Q., …y Huang, K. H. (2017). New developments in the early diagnosis of pancreatic cancer. Expert Review of Gastroenterology and Hepatology, 11(2), 149-156. https://doi.org/10.1080/17474124.2017.1271323
Zhou, Y., …y Zhao, Y. (2024). Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduction and Targeted Therapy, 9, 132. https://doi.org/10.1038/s41392-024-01823-2